<DOC>
	<DOC>NCT02364908</DOC>
	<brief_summary>This study is a biomedical, open label, therapeutic strategy, interventional, non-randomized, multicenter study to evaluate the non compliance to antimalarials in patients with systemic lupus in the Nord Pas-de-Calais region (FRANCE). It is conducted in two visits. These visits consist in obtaining blood sample, performing a clinical examination and filling in a questionnaire (Quality Of Life, Coping...). The goal for the noncompliants patients is to guide them towards the therapeutic education with professionals (nurses and physicians).</brief_summary>
	<brief_title>Prospective Evaluation of Decision and Compliance With Antimalarials in Patients With Systemic Lupus</brief_title>
	<detailed_description />
	<mesh_term>Lupus Erythematosus, Systemic</mesh_term>
	<mesh_term>Antimalarials</mesh_term>
	<criteria>patients with a systemic lupus with ACR criteria (at least 4 criterias) patients with antimalarials for at least 3 months with a minimum dose of 200 mg/day. patients who refuse to sign the informed consent patients who are under guardianship</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>systemic lupus erythematosus</keyword>
	<keyword>antimalarials</keyword>
	<keyword>therapeutic education</keyword>
	<keyword>Coping questionnaire</keyword>
	<keyword>MASRI questionnaire</keyword>
	<keyword>morisky medication adherence scale</keyword>
	<keyword>lupus Quality Of Life</keyword>
	<keyword>internal medicine</keyword>
</DOC>